DURBECEM Trademark

Trademark Overview

On Friday, February 28, 2025, a trademark application was filed for DURBECEM with the United States Patent and Trademark Office. The USPTO has given the DURBECEM trademark a serial number of 99061755. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, August 7, 2025. This trademark is owned by Celgene Corporation. The DURBECEM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; antivirals; antibodies for medical purposes; biological preparations for the treatment of cancer; anticoagulants; stem cells for medical purposes; radiopharmaceutical preparations for the treatment of cancer and solid tumors; diagnostic radiopharmaceutical preparations; diagnostic preparations for medical purposes
durbecem

General Information

Serial Number99061755
Word MarkDURBECEM
Filing DateFriday, February 28, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, August 7, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; antivirals; antibodies for medical purposes; biological preparations for the treatment of cancer; anticoagulants; stem cells for medical purposes; radiopharmaceutical preparations for the treatment of cancer and solid tumors; diagnostic radiopharmaceutical preparations; diagnostic preparations for medical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 28, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08543

Trademark Events

Event DateEvent Description
Friday, February 28, 2025NEW APPLICATION ENTERED
Monday, August 4, 2025ASSIGNED TO EXAMINER
Thursday, August 7, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 7, 2025NON-FINAL ACTION E-MAILED
Thursday, August 7, 2025NON-FINAL ACTION WRITTEN
Tuesday, July 22, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 28, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

durbecem diseases preparations purposes disease cancer medical treatment diagnostic solid radiopharmaceutical